Marc Espie

Marc Espie

UNVERIFIED PROFILE

Are you Marc Espie?   Register this Author

Register author
Marc Espie

Marc Espie

Publications by authors named "Marc Espie"

Are you Marc Espie?   Register this Author

90Publications

2417Reads

7Profile Views

Correlation between tumour characteristics, SUV measurements, metabolic tumour volume, TLG and textural features assessed with F-FDG PET in a large cohort of oestrogen receptor-positive breast cancer patients.

Eur J Nucl Med Mol Imaging 2017 Jul 10;44(7):1145-1154. Epub 2017 Feb 10.

Department of Nuclear Medicine, Saint-Louis Hospital, Assistance Publique - Hôpitaux de Paris, 1 avenue Claude Vellefaux, 75475, Paris Cedex 10, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-017-3641-4DOI Listing
July 2017

Use of iron sucrose and red blood cell transfusions in anaemic cancer patients in France (OncoFer study).

Support Care Cancer 2017 03 3;25(3):973-982. Epub 2016 Dec 3.

Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-016-3489-3DOI Listing
March 2017

10-Year follow-up of 621 patients treated using high-dose rate brachytherapy as ambulatory boost technique in conservative breast cancer treatment.

Radiother Oncol 2017 01 26;122(1):11-16. Epub 2016 Jul 26.

Radiation Oncology Department, Saint Louis Hospital, AP-HP, Paris, France; Radiation Oncology Department, Pitié-Salpétrière Hospital, AP-HP, Paris, France; Breast Cancer Unit, Saint Louis Hospital, AP-HP, Paris, France; University Paris Diderot, Department of Medicine, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2016.06.014DOI Listing
January 2017

[Academic carriers in oncology and radiotherapy: Explanations for the readers of Bulletin du Cancer].

Bull Cancer 2016 Sep 23;103(9):719-29. Epub 2016 Aug 23.

Institut Claudius-Regaud, IUCT-oncopole, université Paul-Sabatier, 31059 Toulouse, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2016.07.004DOI Listing
September 2016

¹⁸F-FDG PET/CT in the early prediction of pathological response in aggressive subtypes of breast cancer: review of the literature and recommendations for use in clinical trials.

Eur J Nucl Med Mol Imaging 2016 May 13;43(5):983-93. Epub 2016 Jan 13.

Department of Nuclear Medicine, Haut-Lévêque Hospital, University of Bordeaux, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-015-3295-zDOI Listing
May 2016

[Intrathecal methotrexate in breast cancer meningeal carcinomatosis - Experience with a new administration schedule].

Bull Cancer 2016 May 15;103(5):444-54. Epub 2016 Mar 15.

AP-HP, hôpital Saint-Louis, centre des maladies du sein, 1, avenue Claude-Vellefaux, 75010 Paris, France; AP-HP, hôpital Saint-Louis, service d'oncologie médicale, 1, avenue Claude-Vellefaux, 75010 Paris, France; Université Paris-Diderot, UFR de médecine, 75890 Paris cedex 18, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2016.02.002DOI Listing
May 2016

¹⁸F-FDG PET/CT for the Early Evaluation of Response to Neoadjuvant Treatment in Triple-Negative Breast Cancer: Influence of the Chemotherapy Regimen.

J Nucl Med 2016 Apr 23;57(4):536-43. Epub 2015 Dec 23.

University Paris-Diderot, PRES Paris Cité, INSERM/CNRS UMR944/7212, Paris, France Department of Medical Oncology, Breast Diseases Center, APHP, Saint-Louis Hospital, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.115.163907DOI Listing
April 2016

Cancer Risk in Women Exposed to Diethylstilbestrol in Utero.

Therapie 2015 Sep-Oct;70(5):433-41. Epub 2015 Jun 12.

Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, Paris Diderot University, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2515/therapie/2015030DOI Listing
December 2015

Early Metabolic Response to Neoadjuvant Treatment: FDG PET/CT Criteria according to Breast Cancer Subtype.

Radiology 2015 Nov 27;277(2):358-71. Epub 2015 Apr 27.

From the Department of Nuclear Medicine (D.G., A.M., P.M.), Department of Statistical Sciences (A.S., M.R.R.), Department of Biochemistry (P.d.C.), Breast Diseases Unit and Department of Medical Oncology (S.G., M.E.), and Department of Pathology (A.d.R.), Saint-Louis Hospital, 1 avenue Claude Vellefaux, 75475 Paris Cedex 10, France; INSERM, UMR 1101 LaTIM, Brest, France (M.M., D.V., M.H.); Department of Nuclear Medicine, CHU Bordeaux, University of Bordeaux, Bordeaux, France (E.H.); and B2T, Doctoral School, IUH, University of Paris VII, Paris, France (D.G., P.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2015141638DOI Listing
November 2015

Does purified Swedish pollen extract, a nonhormonal treatment for vasomotor symptoms, inhibit the CYP2D6 enzyme system?

Menopause 2015 Nov;22(11):1212-4

1New York University School of Medicine, New York, NY 2Saint Louis Hospital, Paris, France 3ANEMO Menopause Center, Nice, France.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/menopausejournal/2015/11000/Doe
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/GME.0000000000000535DOI Listing
November 2015

Ovarian reserve in breast cancer: assessment with anti-Müllerian hormone.

Reprod Biomed Online 2014 Nov 28;29(5):573-80. Epub 2014 Jul 28.

Centre des Maladies du Sein, Hôpital Saint Louis, AP-HP, 1 Avenue Claude Vellefaux, 75010, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rbmo.2014.07.008DOI Listing
November 2014

¹⁸F-FDG-PET/CT in staging, restaging, and treatment response assessment of male breast cancer.

Eur J Radiol 2014 Oct 17;83(10):1925-33. Epub 2014 Jun 17.

Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejrad.2014.05.037DOI Listing
October 2014

[The post-cancer period, a conceptual and epidemiological approach].

Soins 2014 Mar(783):26-9

View Article

Download full-text PDF

Source
March 2014

[Vitamin D and cancers].

Presse Med 2013 Oct 17;42(10):1405-11. Epub 2013 Sep 17.

Hôpital Saint-Louis, service d'oncologie médicale, centre des maladies du sein, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lpm.2013.07.013DOI Listing
October 2013

[Epidemiology and risk factors of breast cancer].

Soins 2013 Jun(776):22-4

Centre de Maladies du sein a l'Hôpital Saint-Louis.

View Article

Download full-text PDF

Source
June 2013

Distinct tumor protein p53 mutants in breast cancer subgroups.

Int J Cancer 2013 Mar 1;132(5):1227-31. Epub 2012 Sep 1.

Département de Biochimie, AP-HP, Hôpital Saint-Louis, Institut Universitaire d'Hématologie, CNRS UMR7212/INSERM U944/University Paris Diderot, Sorbonne Paris Cité, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.27767DOI Listing
March 2013

Performance of FDG PET/CT in the clinical management of breast cancer.

Radiology 2013 Feb 6;266(2):388-405. Epub 2012 Dec 6.

Department of Nuclear Medicine and Department of Medical Oncology, Breast Diseases Unit, Saint-Louis Hospital, 1 avenue Claude Vellefaux, 75475 Paris Cedex 10, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.12110853DOI Listing
February 2013

Prognostic impact of (18)FDG-PET-CT findings in clinical stage III and IIB breast cancer.

J Natl Cancer Inst 2012 Dec 12;104(24):1879-87. Epub 2012 Dec 12.

Service de Médecine Nucléaire, Hôpital Saint-Louis, Assistance publique Hôpitaux de Paris, 1 Ave Claude Vellefaux, 75475 Paris Cedex 10, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djs451DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525816PMC
December 2012

Lymphoscintigraphy can select breast cancer patients for internal mammary chain radiotherapy.

Int J Radiat Oncol Biol Phys 2012 Jul 13;83(4):1081-8. Epub 2011 Dec 13.

Department of Nuclear Medicine, Saint-Louis Hospital, Paris 7 University, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2011.09.016DOI Listing
July 2012

Combining molecular targeted therapies: clinical experience.

Anticancer Drugs 2011 Sep;22(8):701-10

Department of Oncology, University Hospital Jean Minjoz, Besançon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CAD.0b013e328345ffa4DOI Listing
September 2011

Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer.

Eur J Nucl Med Mol Imaging 2011 Mar 6;38(3):426-35. Epub 2010 Nov 6.

Department of Nuclear Medicine, Saint-Louis Hospital, Assistance publique Hôpitaux de Paris, Paris, France.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00259-010-1640-9
Publisher Site
http://dx.doi.org/10.1007/s00259-010-1640-9DOI Listing
March 2011

The sentinel node procedure in breast cancer: nuclear medicine as the starting point.

J Nucl Med 2011 Mar 14;52(3):405-14. Epub 2011 Feb 14.

Nuclear Medicine, Saint-Louis Hospital, University of Paris VII, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.110.081711DOI Listing
March 2011

Breast intracystic papillary carcinoma: an update.

Breast J 2009 Nov-Dec;15(6):639-44. Epub 2009 Sep 7.

Hopitaux de Paris (AP-HP), Hopital Saint-Louis, Service de Pathologie, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1524-4741.2009.00823.xDOI Listing
February 2010

Should FDG PET/CT be used for the initial staging of breast cancer?

Eur J Nucl Med Mol Imaging 2009 Oct;36(10):1539-42

Department of Nuclear Medicine, Hôpital Saint-Louis, Assistance publique-Hopitaux de Paris, 1 avenue Claude Vellefaux, 75475, Paris Cedex 10, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-009-1159-0DOI Listing
October 2009

TP53 status and response to chemotherapy in breast cancer.

Pathobiology 2008 10;75(2):132-9. Epub 2008 Jun 10.

Department of Pathology, Hospital St-Louis, APHP and University Paris 7, INSERM U728, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000123851DOI Listing
July 2008

NF-kappa B genes have a major role in inflammatory breast cancer.

BMC Cancer 2008 Feb 4;8:41. Epub 2008 Feb 4.

Centre Rene Huguenin, FNCLCC, 35 rue Dailly, 92210, St-Cloud, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-8-41DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2267801PMC
February 2008

[Exquisite sensitivity of TP53 mutant breast cancers to dose-dense chemotherapy].

Med Sci (Paris) 2007 Nov;23(11):1021-3

Service de Biochimie et CNRS/ Université Paris VII UMR7151, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1051/medsci/200723111021DOI Listing
November 2007

[Interests and perspectives of PET-CT for breast cancer: review of the literature].

Bull Cancer 2007 Jul;94(7):658-68

Service de médecine nucléaire et centre TEP, Hôpital Saint-Louis, Paris.

View Article

Download full-text PDF

Source
July 2007

[An unusual breast tumor].

Ann Pathol 2006 Jun;26(3):215-6

Service d'Anatomie Pathologique, Hôpital Saint-Louis, 1 avenue Claude Vellefaux, 75475 Paris Cedex 10, France.

View Article

Download full-text PDF

Source
June 2006

[GnRH agonists and breast pathology].

Authors:
Marc Espié

Ann Urol (Paris) 2005 Oct;39 Suppl 3:S59-65

Service d'oncologie médicale, hôpital Saint-Louis, 1, avenue Claude-Vellefaux, 75475 Paris 10, France.

View Article

Download full-text PDF

Source
October 2005

[GnRH analogs and breast cancer].

Authors:
Marc Espié

Rev Prat 2005 ;Spec. No:42-6

Centre des Maladies du Sein, Hôpital Saint Louis, Paris.

View Article

Download full-text PDF

Source
June 2005

[Neoadjuvant treatment of early breast cancer: new drugs contribution].

Bull Cancer 2004 Dec;91 Suppl 4:S232-8

Centre des maladies du sein, Hôpital Saint-Louis, 1 avenue Claude-Vellefaux, Paris 75010.

View Article

Download full-text PDF

Source
December 2004

Molecular profiling of inflammatory breast cancer: identification of a poor-prognosis gene expression signature.

Clin Cancer Res 2004 Oct;10(20):6789-95

Laboratoire d'Oncogénétique - INSERM E0017, Centre René Huguenin, St-Cloud, France.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-04-0306DOI Listing
October 2004

Two prognostic groups of inflammatory breast cancer have distinct genotypes.

Clin Cancer Res 2003 Sep;9(11):4184-9

Institut National de la Santé et de la Recherche Médicale (INSERM) E0017/Oncogénétique, Centre René Huguenin, 35 rue Dailly, F-92211 St-Cloud, France.

View Article

Download full-text PDF

Source
September 2003

High-dose adjuvant chemotherapy for breast cancer: state of the art.

Forum (Genova) 2002 ;12(1):36-40

Centre des Maladies du Sein, Department of Medical Oncology, Hospital Saint-Louis, Paris.

View Article

Download full-text PDF

Source
April 2003

[The limits of screening for breast cancer have some advantages].

Authors:
Marc Espié

Presse Med 2003 Jan;32(3):119

View Article

Download full-text PDF

Source
January 2003

[Mass screening for breast cancer].

Presse Med 2003 Jan;32(3):120-4

Centre des maladies du sein, hôpital Saint-Louis, Paris.

View Article

Download full-text PDF

Source
January 2003

[Breast imaging and biopsy procedures in the diagnosis of breast cancer].

Presse Med 2003 Jan;32(3):125-33

Radiologie, Centre des Maladies du Sein, Hôpital Saint Louis, Paris.

View Article

Download full-text PDF

Source
January 2003

[Ductal carcinomas in situ].

Presse Med 2003 Jan;32(3):134-40

Anatomopathologie, Centre des Maladies du Sein, Oncologie Médicale, Hôpital Saint Louis, Paris. .

View Article

Download full-text PDF

Source
January 2003

Increased incidence of ERBB2 overexpression and TP53 mutation in inflammatory breast cancer.

Oncogene 2002 Oct;21(49):7593-7

Service de Biochimie B and CNRS UPR9051, Hôpital Saint Louis, 1, Avenue Claude Vellefaux, F-75475 Paris Cedex 10, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1205932DOI Listing
October 2002